The economics of cybersecurity in the healthcare industry is not just about money, but about making the best decisions to protect an organization’s ability to create value, according to Scott Borg, chief economist at the US Cyber Consequences Unit. Healthcare cybersecurity executives need to understand how the systems that protect assets create value and prioritize their efforts accordingly. They also need to consider how attackers can benefit from different types of attacks, particularly with the rise of the Internet of Things.
Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario
Private equity-backed Clario brings to Thermo Fisher Scientific software that collects, manages, and analyzes clinical trial endpoint data. Analysts see Clario’s offerings as highly complementary
